MapLight Therapeutics (MPLT) Retained Earnings (2024 - 2026)
MapLight Therapeutics (MPLT) posted Retained Earnings of -$228000.0 for Q4 2025, up 99.92% sequentially from -$281.0 million in Q3 2025, and down 239.88% YoY from $163000.0 in Q4 2024.
MapLight Therapeutics (MPLT) Retained Earnings (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Retained Earnings for 2 years, with the latest figure at -$228000.0 in Q4 2025.
- Quarterly Retained Earnings fell 239.88% year-over-year to -$228000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$228000.0 (down 239.88% YoY) and the FY2025 annual result came in at -$228000.0, down 239.88% from the prior year.
- Retained Earnings grew to -$228000.0 in Q4 2025 per MPLT's latest filing, from -$281.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $163000.0 in Q4 2024 and troughed at -$281.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | -481.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -481.40 Mn |
| Dec 31, 2025 | -228,000.00 |
| Sep 30, 2025 | -281.00 Mn |
| Dec 31, 2024 | 163,000.00 |